Dextran, high molecular weight Interactions
There are 33 drugs known to interact with dextran, high molecular weight, along with 4 disease interactions. Of the total drug interactions, 24 are major, and 9 are moderate.
- View all 33 medications that may interact with dextran, high molecular weight
- View dextran, high molecular weight disease interactions (4)
Most frequently checked interactions
View interaction reports for dextran, high molecular weight and the medicines listed below.
- Advair Diskus (fluticasone / salmeterol)
- Armour Thyroid (thyroid desiccated)
- Aspir 81 (aspirin)
- Auvelity (bupropion / dextromethorphan)
- Cardizem (diltiazem)
- Concerta (methylphenidate)
- Ecotrin Adult Low Strength (aspirin)
- Eliquis (apixaban)
- Emgality (galcanezumab)
- Hyzaar (hydrochlorothiazide / losartan)
- Imodium (loperamide)
- Lamictal (lamotrigine)
- Lexapro (escitalopram)
- Linzess (linaclotide)
- Mucinex (guaifenesin)
- Nexium 24HR (esomeprazole)
- Nitrostat (nitroglycerin)
- NP Thyroid (thyroid desiccated)
- Nurtec ODT (rimegepant)
- Ozempic (semaglutide)
- Plavix (clopidogrel)
- Prinzide (hydrochlorothiazide / lisinopril)
- ProAir HFA (albuterol)
- Restoril (temazepam)
- Ritalin (methylphenidate)
- Spiriva (tiotropium)
- Stiolto Respimat (olodaterol / tiotropium)
- Syfovre (pegcetacoplan ophthalmic)
- Valium (diazepam)
- Vistaril (hydroxyzine)
Dextran, high molecular weight disease interactions
There are 4 disease interactions with dextran, high molecular weight which include:
More about dextran, high molecular weight
- dextran, high molecular weight consumer information
- Compare alternatives
- Side effects
- Drug class: plasma expanders
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.